Kang et al. hypothesized that MMR gene mutations could be associated with the high occurrence of secondary cancer in EMPD and investigated the MMR status and the presence of gene mutation in MLH1, PMS1, MSH2, and MSH6 in 20 patients with EMPD (68). The gene discussed is MLH1; the disease is cancer.